Dr. William G. Rice, Chairman, President and CEO of Aptose, will present on May 5, 2025 and will be hosting one-on-one meetings during the conference. To schedule a one-on-one meeting with Aptose ...

West African scammers known as ‘grazers’ – or 419ers in Nigeria – promise huge fortunes after eliciting sympathy from ...

NASCAR drivers have always taken up a fight against personal atrocities that have struck their near ones. The post Fueled by ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

A cancer charity has urged individuals to monitor any unexplained bruising and to seek medical advice if they experience key ...

Researchers sought to determine whether MSD HSCT or auto-HSCT would have advantages over chemotherapy in post-remission treatment for patients with AML.

Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification.

Mark Litzow, MD, discusses the challenges of using immunotherapy for the treatment of acute lymphoblastic leukemia.

Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah ...

Tech expert Kurt “CyberGuy" Knutsson says an Apple Watch saved psychiatrist Amanda Faulkner by detecting deadly leukemia ...